ABSTRACT-The effects of AL-3264, which exhibits a 5-lipoxygenase (5-LO) inhibiting property by block ing histamine H1-receptors and inhibition of histamine release, were examined on leukotriene (LT) pro duction and LT-mediated responses. AL-3264 (1 30 tiM) inhibited the A23,187-induced LT production from human leukocytes with almost the same potency as that of nordihydroguaiaretic acid. AL-3264 (30 100 mg/kg, p.o.) inhibited the antigen-induced LT production in the abdominal cavity of passively sen sitized rats; its effect was as potent as that of AA-861, a 5-LO inhibitor. AL-3264 (30,uM) suppressed both the initial and sustained phases of the antigen-induced contractions in isolated trachea from actively sensi tized guinea pig. Phenidone (3 1M), a dual inhibitor of 5-LO and cyclooxygenase (CO), suppressed the sus tained phase, while indomethacin was without effect on either phase. AL-3264 (40-160 mg/kg, p.o.) sup pressed the arachidonic acid-induced ear edema in mice, for which 5-LO inhibitors were effective but antihistamines were not. The anti-edematous effect of AL-3264 (160 mg/kg) was reduced by intradermal ad ministration of LTC4 (0.1 pg). These results suggest that AL-3264 suppresses LT production in vivo and in vitro by inhibiting 5-LO activity, and this property may contribute to the antiallergic effect of AL-3264.
Leukotrienes (LTs), which are derived from arach idonic acid by 5-lipoxygenase (5-LO), have been implicated in the pathophysiology of allergic and inflammatory dis eases, especially bronchial asthma. For example, peptido LTs are detected in the blood from individuals with acute asthma (1) and in nasal exudates after antigen challenge in patients allergic to ragweed (2) . In addition, peptido LTs contract isolated human bronchus (3), cause bron choconstriction in normal and asthmatic subjects (4, 5) and stimulate mucus secretion from the trachea of the dog (6) and mucous glycoprotein secretion from human airways in vitro (7) . Furthermore, peptido-LTs increase microvascular permeability in guinea pig trachea (8) and human skin (9) . On the other hand, LTB4 induces the chemotaxis of eosinophils and neutrophils (10, 11) . Thus, receptor antagonists and biosynthesis inhibitors of LTs have been considered to be highly valuable for the thera py of allergic and inflammatory diseases.
We have demonstrated that N-[4-[4-(diphenylmethyl) 1-piperazinyl]butyl]-3-(6-methyl-3-pyridyl) acrylamide (AL-3264, Fig. 1 ) inhibits 5-LO activity from guinea pig exudate cells in a cell-free system (12) , blocks histamine H1-receptors in isolated guinea pig trachea and inhibits antigen-induced histamine release from isolated rat peritoneal mast cells. However, there is no evidence that AL-3264 inhibits LT production as the result of its 5-LO inhibition. Furthermore, although there are a number of compounds that inhibit 5-LO activity or LT production in vitro, only a few compounds, such as zileuton, ICI D2138 and WY-50,295 (13) (14) (15) , have so far provided effective inhibition of in vivo LT production in humans or Drugs were suspended in a 0.5% tragacanth solution for oral administration. In the in vitro tests, they were dis solved in ethanol or dimethyl sulfoxide and diluted with the medium used. The doses of drugs described in this paper refer to the forms described above.
A23,187-induced production of L Ts in human peripheral leukocytes in vitro Peripheral venous blood (30 ml) from healthy volun teers was collected in heparinized (20 units/ml) tubes and mixed with 7.5 ml of saline containing 6% dextran and 3% glucose. The blood was allowed to sediment at room temperature for 60 min. The leukocyte-rich plasma layer was withdrawn, diluted with an equal volume of Tris buffer and then layered onto 15 ml of Lymphocyte Separa tion Medium. After centrifuging the tubes at 2,000 rpm for 30 min at room temperature, the supernatants were discarded. The cell pellets were exposed to 0.2% NaCI so lution for 30 sec to lyse erythrocytes and then immediately exposed to 0.9% NaCI solution. After centrifugation at 1,400 rpm for 10 min, the cells were washed twice with Ca21-free Tyrode solution and resuspended into Tyrode solution to a concentration of 3 x 105 leukocytes/890 p1. The drug solution examined or the vehicle (100 pl) was add ed to the cell suspension (890 pl). After incubation at 371C for 30 min, 10 pl of 0.1 mM A23,187 (final concent ration of 1 pM in 0.2% dimethyl sulfoxide) were added to the cell suspension. After incubation for a further 15 min, the reaction was terminated by placing the test tubes into ice-water. The cell suspension was centrifuged at 2,000 rpm for 10 min at 41C. The supernatant was stocked at 80'C until the LT assay. The levels of LTB4 and the total levels of LTs C4, D4 and E4 were determined using LTB4 and LT C4/D4/E4 radioimmunoassay kits, respec tively. All experiments were run in duplicate.
The composition of Tris buffer was 25.0 mM Tris HCI, 120.0 mM NaCI and 5.0 mM KCI; and the composition of Tyrode solution was 136.9 mM NaCl, 2.7 mM KCI, 1.8 mM CaC12, 1.0 MM MgC12, 0.4 mM NaH2PO4, 11.9 MM NaHCO3 and 5.6 mM glucose.
Antigen-induced L T production in the abdominal cavity of passively sensitized rats This experiment was carried out according to the method of Ross et al. (16) . Rat antiserum to egg albumin (EA) was prepared according to the method of Tada and Okumura (17) . Briefly, EA (10 mg) mixed with 1010 cells of inactive Bordetella pertussis was injected into four footpads of rats. Five days later, EA (5 mg) was injected intramuscularly into the back of the rats. The antiserum was obtained by cardiopuncture 7 to 10 days after the sec ond injection of EA. The diluted solution (1 ml) of the se rum was intraperitoneally administered to rats (180-250 g). Two hours later, Tyrode solution (5 ml) containing EA (0.4 mg/ml) and heparin (0.2 units/ml) was ad ministered intraperitoneally to the rats. Ten minutes later, the rats were killed, and peritoneal exudates were collected. The exudates were centrifuged at 2,000 rpm for 8 min at 4C. Ethanol was added to the supernatants in the volume ratio of 4:1 and mixed. The mixture was cen trifuged at 3,000 rpm for 15 min at 41C, and the super natant was stocked at 80V until the LT assay. The total level of LTs C4, D4 and E4 was determined using LT C4/ D4/E4 radioimmunoassay kits. Drugs were administered 5 (i.v.), 15 (p.o.) or 30 (p.o.) min before EA challenge.
Antigen-induced contractions in isolated trachea from sensitized guinea pig EA (0.2%) saline solution was emulsified with Freund complete adjuvant in an equal volume. The emulsion (1 ml) was subcutaneously injected into the planta of the four legs of each guinea pig (300-450 g). Three to four weeks after the sensitization, the trachea was removed and cut into three zig-zag strips as described by Emmer son and Mackay (18) . One of them served as the control. The strips were suspended in a 10-ml organ bath filled with Tyrode solution, kept at 371C and gassed with 95% 02 and 5%1o CO2. The tension of the strips was measured by isometric force transducers (TB-611T; Nihon Kohden, Tokyo). The strips were allowed to equilibrate for more than 1 hr with an initial loading tension of 1 g. The maxi mum contractions of the strips induced by histamine (0.1-1 mM) were determined.
After washing and equilibration, EA (10 pg/100 pl) was added to the bath, and the tension of the strips was recorded for 60 min. Drugs were added to the organ baths at 5 min before the EA challenge. The contractions induced by EA were ex pressed as a percentage of the maximum response to hista mine.
Arachidonic acid-induced ear edema in mice
The method described by Young et al. (19) was used with minor modifications. Briefly, 20 pl of the acetone so lution of arachidonic acid (AA, 12.5 mg/ml) was applied to both the inner and outer surfaces of the right ears of mice (18-23 g ). One hour later, the mice were killed by in halation of C02 gas. A circular part (5.5 mm in diameter) of both ears was removed with a metalic punch and weighed. The left ears of the mice served as the control. Ear swelling was expressed as a percentage of the increase in weight of the AA-treated ear compared to that of the contralateral untreated ear. Drugs were orally administered 1 hr before AA application.
In some experiments, LTC4 saline solution (0.1 pg/ 10
,pl/ear) was intradermally administered in the right ears of the mice immediately before AA application or PGE2 (1 pg/20 pl/ear) was topically applied to the right ears of mice together with AA solution.
Statistical analyses
The statistical significance between means was analyzed by variance analysis followed by Scheffe's multiple-com parison test and Student's t-test. The IC50-value, the con centration that is necessary to obtain 50% inhibition of the responses, was determined from the best fit regression line of the dose-response curve. NDGA, respectively (Fig. 2) . In addition, AL-3264 in hibited the A23,187-induced LTB4 production with an IC50-value of 5.6 [M. Fig. 3 . Effect of AL-3264 on antigen-induced contractions in isolated trachea from actively sensitized guinea pig. Sensitized guinea pig trachea was challenged with egg albumin (10 pg), and the tension of the trachea was measured isometrically. Drugs were added 5 min before the antigen challenge. Each point represents the mean of 4 to 6 preparations. Vertical bar: antigen-induced contractions that were expressed as a percentage of the maximum response to histamine. 0: control, 0: drug-treated group. *P <0.05 and **P <0.01: significantly different from the matched control (Student's t-test).
Antigen-induced LT production in the abdominal cavity of passively sensitized rats The total content of LTs C4, D4 and E4 in the peritoneal exudate was 76.1 ±2.4 ng/ml (mean ±S.E.M., n=27) at 10 min after i.p. administration of EA to passively sensi tized rats. When AL-3264 was orally administered 15 or 30 min before the EA challenge, AL-3264 (30 and 100 mg/kg) decreased the LT content in the peritoneal exu date. When i.v. administered 5 min before the EA challenge, AL-3264 at 3 mg/kg also decreased the LT con tent with the same potency as AA-861, a 5-LO inhibitor. NDGA was inactive up to 10 mg/kg, i.v. (Table 1) .
Antigen-induced contractions in isolated trachea from actively sensitized guinea pigs
As shown in Fig. 3 , EA (10 pg) caused a long lasting contraction in isolated trachea from actively sensitized guinea pigs. The contraction induced by EA was little affected by repeated washing with Tyrode solution 60 min after the antigen challenge. AL-3264 at 30 pM suppressed the initial and sustained phases of the antigen-induced contraction. Phenidone at 3 pM suppressed the sustained phase of the contraction, while mepyramine and ketotifen at 10 pM suppressed the initial phase of the contraction. Indomethacin did not affect the two phases of contraction at 1 pM but rather augmented it at 10 pM (data not shown).
Arachidonic acid-induced ear edema in mice
Topical application of AA (0.25 mg) to the right ear of mice caused acute edema that reached a peak at 1 hr after AA application. The swelling rate in AA-treated ears was 133±4% (mean±S.E.M., n=24) at 1 hr after topical ap plication of AA. AL-3264 (40-160 mg/kg) suppressed the AA-induced ear edema when AL-3264 was orally ad ministered 1 hr before AA application. Zileuton (40 and 80 mg/kg, p.o.) also suppressed the ear edema in a dose related manner (Fig. 4) . The anti-edematous effect of AL-3264 (160 mg/kg) in the AA-induced ear edema was reduced by concomitant application of LTC4 (0.1 ttM), but not by PGE2 (1 PM) (Fig. 5) . However, the AA-induced ear edema was not affected by concomitant application of LTC4 (0.1 pM) or PGE2 (1 l-M) (data not shown).
DISCUSSION
In the present study, AL-3264 was found to inhibit the A23,187-induced production of LTs C4, D4 and E4 in hu man peripheral leukocytes in vitro with an IC50-value of 3.1 pM. AL-3264 was more potent than ketotifen and two times less potent than NDGA in inhibiting the LT produc tion. In addition, AL-3264 inhibited the A23,187-induced production of LTB4 with an IC50-value of 5.6 pM. Fur thermore, orally administered AL-3264 inhibited the anti gen-induced production of LTs C4, D4 and E4 in the ab dominal cavity of passively sensitized rats. In this inhibi tion, AL-3264 was as potent as AA-861, a 5-LO inhibitor, which has been demonstrated to inhibit potently the 5-LO of guinea pig peritoneal leukocytes with an IC50-value of 0.8 pM (20) . From these results and our previous ones (12) demonstrating that AL-3264 inhibits 5-LO from guinea pig leukocytes in vitro, it is suggested that AL 3264 inhibits LT production in human peripheral leuko cytes and in the abdominal exudates of passively sensi tized rats, as the result of its inhibition of 5-LO activity.
These results led us to examine the effect of AL-3264 on allergic and inflammatory responses in which LTs have been reported to be involved. First, the effect of AL-3264 on antigen-induced contraction of isolated trachea from sensitized guinea pigs was examined. This contraction has been reported to be mainly mediated by histamine and leu kotrienes (21) : the initial and sustained phases of the con traction are mediated by histamine and LTs, respectively. The involvement of LTs in the sustained phase was fur ther supported by the selective inhibitory effect of ONO 1078, a LT antagonist, in a study using sensitized guinea pig trachea (22) . In the present study, phenidone, a dual inhibitor of 5-LO and cyclooxygenase (CO), suppressed the sustained phase. The results with phenidone were in accordance with those of Adams and Lichtenstein (21) . On the other hand, indomethacin, a CO inhibitor, was without effect on the contraction at low doses and rather enhanced the sustained phase at a high dose; the result being consistent with that of Hand and Buckner (23) . Ac cordingly, the suppressive effect of phenidone on the sus tained phase may be possibly due to a decrease in LT production resulting from 5-LO inhibition. AL-3264 was found to suppress not only the initial phase but also the sustained phase. From these results and a result that AL 3264 did not exert any inhibitory effect on LT-induced contractions in isolated guinea pig trachea (K. Ishii, un published observation), it is conceivable that the effect of AL-3264 on the sustained phase is through its inhibition of LT production.
Furthermore, the effect of AL-3264 on AA-induced ear edema in mice was examined. This ear edema has been shown to be suppressed by 5-LO inhibitors and some CO inhibitors, although the former is more potent than the latter in suppressing the ear edema (19, 24) . We have got evidence that LTs and PGs are mainly involved in AA (0.25 mg)-induced ear edema in mice (25) . In the present study, AL-3264 suppressed the AA-induced ear edema at oral doses over 40 mg/kg as well as zileuton, which was chosen as a reference drug because its potent oral activity is superior to that of AA-861 (26) . AL-3264 has no inhibi tory effect on carrageenan-induced edema in rat hind paw at an oral dose of 80 mg/kg (K. Ishii, unpublished obser vation), suggesting that AL-3264 does not inhibit CO activity. Accordingly, it is probable that AL-3264 sup presses the AA-induced ear edema in mice through inhibi tion of LT production.
We have recently developed a useful method by which the mode of the anti-inflammatory effect of 5-LO and CO inhibitors can be differentially clarified (25) . Namely, the suppressive effect of zileuton on AA-induced ear edema was reduced by LTC4 injected intradermally to the ear im mediately before AA application, but not affected by PGE2 applied topically to the ear together with AA. On the other hand, the anti-edematous effect of indometh acin was reduced by PGE2, but not by LTC4. When AL 3264 was tested in this method, it was found that the anti edematous effect of AL-3264 was reduced by LTC4, but not by PGE2, as in the case of zileuton. These results sug gest that inhibition of LT production by AL-3264 contrib utes to its suppressive effect on the AA-induced ear edema in mice.
In conclusion, AL-3264 inhibits LT production in vivo and in vitro. These effects of AL-3264 is probably due to the inhibition of 5-LO, but the possibility that AL-3264 also inhibits the release process of LT can not be ruled out. The property of AL-3264 to inhibit LT production seems to play an important role in its antiallergic effects.
